Low anterior resection syndrome after rectal cancer surgery: mechanisms, assessment, management, and the potential role of robotic surgery

Rectal cancer is one of the most commonly diagnosed malignancies in the digestive system. In recent years, with continuous advances in systemic therapies such as chemotherapy and radiotherapy, as well as the widespread implementation of the multidisciplinary team (MDT) approach, the prognosis for rectal cancer patients has seen substantial improvement. Radical surgical resection, guided by the principle of total mesorectal excision (TME), still forms the foundation of rectal cancer treatment. Recently, the da Vinci surgical robotic system, owing to its high-definition three-dimensional visualization, multi-degree-of-freedom articulated instruments, and stable, flexible camera platform, has been increasingly adopted in radical rectal cancer surgery. With this technological advancement, sphincter preservation has become feasible for a greater proportion of low rectal cancer patients, thereby sphincter-preserving surgery has become feasible for a greater proportion of patients with low rectal cancer. However, the increasing use of sphincter-preserving surgery has been accompanied by a rising incidence of postoperative functional disorders, most notably low anterior resection syndrome (LARS). A combination of symptoms, including increased bowel frequency, urgency, fecal incontinence, and evacuation problems, defines LARS, leading to significant disruptions in bowel function, psychological health, and quality of life. The mechanisms underlying LARS remain incompletely understood. To prevent or alleviate the occurrence of LARS, enhance postoperative bowel function, and improve the quality of life in patients following low anterior resection for rectal cancer, this review summarizes recent advances in rectal cancer-related treatments and provides an overview of the current insights into the mechanisms, assessment, prevention, and management of LARS, aiming to provide evidence-based recommendations for clinical practice.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-04-01
DOI
https://doi.org/10.3389/fonc.2026.1784483
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low anterior resection syndrome after rectal cancer surgery: mechanisms, assessment, management, and the potential role of robotic surgery

Zhigang Wu, Zhenguo Han, Chenyu Zhang, Tengfei Wang et al.
Frontiers in Oncology
Colorectal Cancer Surgical Treatments
article

Low anterior resection syndrome after rectal cancer surgery: mechanisms, assessment, management, and the potential role of robotic surgery

Zhigang Wu, Zhenguo Han, Chenyu Zhang, Tengfei Wang, Yuzhou Mei
article en

Abstract

Rectal cancer is one of the most commonly diagnosed malignancies in the digestive system. In recent years, with continuous advances in systemic therapies such as chemotherapy and radiotherapy, as well as the widespread implementation of the multidisciplinary team (MDT) approach, the prognosis for rectal cancer patients has seen substantial improvement. Radical surgical resection, guided by the principle of total mesorectal excision (TME), still forms the foundation of rectal cancer treatment. Recently, the da Vinci surgical robotic system, owing to its high-definition three-dimensional visualization, multi-degree-of-freedom articulated instruments, and stable, flexible camera platform, has been increasingly adopted in radical rectal cancer surgery. With this technological advancement, sphincter preservation has become feasible for a greater proportion of low rectal cancer patients, thereby sphincter-preserving surgery has become feasible for a greater proportion of patients with low rectal cancer. However, the increasing use of sphincter-preserving surgery has been accompanied by a rising incidence of postoperative functional disorders, most notably low anterior resection syndrome (LARS). A combination of symptoms, including increased bowel frequency, urgency, fecal incontinence, and evacuation problems, defines LARS, leading to significant disruptions in bowel function, psychological health, and quality of life. The mechanisms underlying LARS remain incompletely understood. To prevent or alleviate the occurrence of LARS, enhance postoperative bowel function, and improve the quality of life in patients following low anterior resection for rectal cancer, this review summarizes recent advances in rectal cancer-related treatments and provides an overview of the current insights into the mechanisms, assessment, prevention, and management of LARS, aiming to provide evidence-based recommendations for clinical practice.

Frontiers in OncologyVol. 16
Shanxi Academy of Medical Sciences (CN)
Shanxi Medical University
Openalex Percentile: Top 37%
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.